India Glycols Limited (BOM:500201)
India · Delayed Price · Currency is INR 1,014.55
+24.85 (2.51%)
At close: May 25, 2026
India Glycols Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 42,114 | 37,683 | 32,940 | 26,509 | 28,683 | |
Revenue Growth (YoY) | 11.76% | 14.40% | 24.26% | -7.58% | 23.79% |
Cost of Revenue | 30,625 | 24,630 | 21,904 | 16,207 | 19,628 |
Gross Profit | 11,489 | 13,052 | 11,036 | 10,302 | 9,055 |
Selling, General & Admin | 1,326 | 1,328 | 1,138 | 914.33 | 934.53 |
Other Operating Expenses | 3,671 | 6,190 | 5,694 | 6,103 | 4,137 |
Operating Expenses | 6,550 | 8,670 | 7,847 | 7,957 | 7,183 |
Operating Income | 4,939 | 4,382 | 3,189 | 2,345 | 1,872 |
Interest Expense | -1,672 | -1,385 | -1,051 | -850.11 | -579.92 |
Interest & Investment Income | - | 143.77 | 235.81 | 247.17 | 242.51 |
Earnings From Equity Investments | 464.2 | 464.01 | 166.63 | 113.72 | 208.83 |
Currency Exchange Gain (Loss) | - | -432.42 | -189.42 | -370.44 | -190.77 |
Other Non Operating Income (Expenses) | 49.3 | -259.61 | -158.6 | -132.54 | -76.32 |
EBT Excluding Unusual Items | 3,780 | 2,913 | 2,193 | 1,353 | 1,476 |
Gain (Loss) on Sale of Investments | - | - | 1.76 | 1.34 | 1.46 |
Gain (Loss) on Sale of Assets | - | 10.15 | 38.85 | 14.34 | -0.9 |
Other Unusual Items | -8.3 | - | - | 281.36 | 2,213 |
Pretax Income | 3,772 | 2,923 | 2,233 | 1,650 | 3,690 |
Income Tax Expense | 844.5 | 613.95 | 503.22 | 239.63 | 394.26 |
Earnings From Continuing Operations | 2,928 | 2,309 | 1,730 | 1,410 | 3,296 |
Earnings From Discontinued Operations | - | - | - | - | 102.67 |
Net Income to Company | 2,928 | 2,309 | 1,730 | 1,410 | 3,399 |
Minority Interest in Earnings | - | - | - | -159.59 | - |
Net Income | 2,928 | 2,309 | 1,730 | 1,251 | 3,399 |
Net Income to Common | 2,928 | 2,309 | 1,730 | 1,251 | 3,399 |
Net Income Growth | 26.78% | 33.49% | 38.30% | -63.19% | 158.23% |
Shares Outstanding (Basic) | 64 | 62 | 62 | 62 | 62 |
Shares Outstanding (Diluted) | 64 | 62 | 62 | 62 | 62 |
Shares Change (YoY) | 2.89% | - | - | - | - |
EPS (Basic) | 45.95 | 37.29 | 27.94 | 20.20 | 54.88 |
EPS (Diluted) | 45.95 | 37.29 | 27.94 | 20.20 | 54.88 |
EPS Growth | 23.22% | 33.49% | 38.30% | -63.19% | 158.23% |
Free Cash Flow | -543.1 | -3,984 | -1,144 | -1,131 | -2,639 |
Free Cash Flow Per Share | -8.52 | -64.33 | -18.48 | -18.26 | -42.62 |
Dividend Per Share | - | 5.000 | 4.000 | 3.750 | 3.750 |
Dividend Growth | - | 25.00% | 6.67% | - | 25.00% |
Gross Margin | 27.28% | 34.64% | 33.50% | 38.86% | 31.57% |
Operating Margin | 11.73% | 11.63% | 9.68% | 8.85% | 6.53% |
Profit Margin | 6.95% | 6.13% | 5.25% | 4.72% | 11.85% |
Free Cash Flow Margin | -1.29% | -10.57% | -3.47% | -4.26% | -9.20% |
EBITDA | 6,493 | 5,444 | 4,121 | 3,193 | 2,621 |
EBITDA Margin | 15.42% | 14.45% | 12.51% | 12.05% | 9.14% |
D&A For EBITDA | 1,554 | 1,062 | 931.6 | 848.19 | 749.6 |
EBIT | 4,939 | 4,382 | 3,189 | 2,345 | 1,872 |
EBIT Margin | 11.73% | 11.63% | 9.68% | 8.85% | 6.53% |
Effective Tax Rate | 22.39% | 21.00% | 22.53% | 14.52% | 10.68% |
Revenue as Reported | 98,316 | 90,535 | 79,473 | 66,655 | 66,229 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.